Active anti-inflammatory metabolite of sulfasalazine — local action in colon mucosa via COX/LOX inhibition + scavenging of reactive oxygen species. First-line for mild-to-moderate ulcerative colitis; pH- and time-controlled formulations target distal ileum/colon.